Therefore, keep exploring the role of PRL and its targeted therapies in the mechanism of endocrine therapy resistance in breast cancer plays a significant role in its becoming a method to overcome endocrine therapy resistance clinically. This evidence concerns the gene PRL and breast carcinoma.